
Company valuation, historical trends, and peer comparisons.
According to Illumina, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 35.53B. This represents a change of 26.27% compared to the average of 28.14B of the last 4 quarters.
The mean historical Enterprise Value of Illumina, Inc. over the last ten years is 34.92B. The current 35.53B Enterprise Value has changed 1.77% with respect to the historical average. Over the past ten years (40 quarters), ILMN's Enterprise Value was at its highest in in the July 2021 quarter at 65.60B. The Enterprise Value was at its lowest in in the March 2025 quarter at 14.11B.
Average
34.92B
Median
31.68B
Minimum
18.61B
Maximum
56.83B
Discovering the peaks and valleys of Illumina, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.45%
Maximum Annual Enterprise Value = 56.83B
Minimum Annual Increase = -43.00%
Minimum Annual Enterprise Value = 18.61B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 21.98B | -3.31% |
| 2024 | 22.73B | 0.61% |
| 2023 | 22.59B | -30.25% |
| 2023 | 32.39B | -43.00% |
| 2022 | 56.83B | 7.97% |
| 2021 | 52.63B | 12.66% |
| 2019 | 46.72B | 6.90% |
| 2018 | 43.70B | 41.11% |
| 2017 | 30.97B | 66.45% |
| 2016 | 18.61B | -32.02% |
The current Enterprise Value of Illumina, Inc. (ILMN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.44B
5-year avg
31.31B
10-year avg
34.92B
Illumina, Inc.’s Enterprise Value is less than Natera, Inc. (55.64B), greater than Guardant Health, Inc. (23.64B), greater than BillionToOne, Inc. (4.77B), greater than Personalis, Inc. (1.64B), greater than GeneDx Holdings Corp. (2.10B), greater than NeoGenomics, Inc. (745.55M), greater than Myriad Genetics, Inc. (662.98M), greater than SOPHiA GENETICS S.A. (567.93M), greater than Pacific Biosciences of California, Inc. (1.41B), greater than 10x Genomics, Inc. (7.42B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 55.64B | $56.49B | |
| 23.64B | $23.00B | |
| 4.77B | $5.18B | |
| 1.64B | $1.69B | |
| 2.10B | $2.00B | |
| 745.55M | $2.18B | |
| 662.98M | $567.68M | |
| 567.93M | $613.77M | |
| 1.41B | $760.11M | |
| 7.42B | $7.84B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Illumina, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Illumina, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Illumina, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Illumina, Inc. (ILMN)?
What is the 3-year average Enterprise Value for Illumina, Inc. (ILMN)?
What is the 5-year average Enterprise Value for Illumina, Inc. (ILMN)?
How does the current Enterprise Value for Illumina, Inc. (ILMN) compare to its historical average?